Pulmonary sporotrichosis: An evolving clinical paradigm

Ar Kar Aung, Denis W. Spelman, Philip J. Thompson

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

In recent decades, sporotrichosis, caused by thermally dimorphic fungi Sporothrix schenckii complex, has become an emerging infection in many parts of the world. Pulmonary infection with S. schenckii still remains relatively uncommon, possibly due to underrecognition. Pulmonary sporotrichosis presents with distinct clinical and radiological patterns in both immunocompetent and immunocompromised hosts and can often result in significant morbidity and mortality despite treatment. Current understanding regarding S. schenckii biology, epidemiology, immunopathology, clinical diagnostics, and treatment options has been evolving in the recent years with increased availability of molecular sequencing techniques. However, this changing knowledge has not yet been fully translated into a better understanding of the clinical aspects of pulmonary sporotrichosis, as such current management guidelines remain unsupported by high-level clinical evidence. This article examines recent advances in the knowledge of sporotrichosis and its application to the difficult challenges of managing pulmonary sporotrichosis. © 2015 by thie Medical publishers,inc.
Original languageEnglish
Pages (from-to)756-766
Number of pages11
JournalSeminars in Respiratory and Critical Care Medicine
Volume36
Issue number5
DOIs
Publication statusPublished - Oct 2015

Cite this

@article{f7e7be27ce524b99bba5160f2c22f7fb,
title = "Pulmonary sporotrichosis: An evolving clinical paradigm",
abstract = "In recent decades, sporotrichosis, caused by thermally dimorphic fungi Sporothrix schenckii complex, has become an emerging infection in many parts of the world. Pulmonary infection with S. schenckii still remains relatively uncommon, possibly due to underrecognition. Pulmonary sporotrichosis presents with distinct clinical and radiological patterns in both immunocompetent and immunocompromised hosts and can often result in significant morbidity and mortality despite treatment. Current understanding regarding S. schenckii biology, epidemiology, immunopathology, clinical diagnostics, and treatment options has been evolving in the recent years with increased availability of molecular sequencing techniques. However, this changing knowledge has not yet been fully translated into a better understanding of the clinical aspects of pulmonary sporotrichosis, as such current management guidelines remain unsupported by high-level clinical evidence. This article examines recent advances in the knowledge of sporotrichosis and its application to the difficult challenges of managing pulmonary sporotrichosis. {\circledC} 2015 by thie Medical publishers,inc.",
author = "Aung, {Ar Kar} and Spelman, {Denis W.} and Thompson, {Philip J.}",
year = "2015",
month = "10",
doi = "10.1055/s-0035-1562901",
language = "English",
volume = "36",
pages = "756--766",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "5",

}

Pulmonary sporotrichosis : An evolving clinical paradigm. / Aung, Ar Kar; Spelman, Denis W.; Thompson, Philip J.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 36, No. 5, 10.2015, p. 756-766.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Pulmonary sporotrichosis

T2 - An evolving clinical paradigm

AU - Aung, Ar Kar

AU - Spelman, Denis W.

AU - Thompson, Philip J.

PY - 2015/10

Y1 - 2015/10

N2 - In recent decades, sporotrichosis, caused by thermally dimorphic fungi Sporothrix schenckii complex, has become an emerging infection in many parts of the world. Pulmonary infection with S. schenckii still remains relatively uncommon, possibly due to underrecognition. Pulmonary sporotrichosis presents with distinct clinical and radiological patterns in both immunocompetent and immunocompromised hosts and can often result in significant morbidity and mortality despite treatment. Current understanding regarding S. schenckii biology, epidemiology, immunopathology, clinical diagnostics, and treatment options has been evolving in the recent years with increased availability of molecular sequencing techniques. However, this changing knowledge has not yet been fully translated into a better understanding of the clinical aspects of pulmonary sporotrichosis, as such current management guidelines remain unsupported by high-level clinical evidence. This article examines recent advances in the knowledge of sporotrichosis and its application to the difficult challenges of managing pulmonary sporotrichosis. © 2015 by thie Medical publishers,inc.

AB - In recent decades, sporotrichosis, caused by thermally dimorphic fungi Sporothrix schenckii complex, has become an emerging infection in many parts of the world. Pulmonary infection with S. schenckii still remains relatively uncommon, possibly due to underrecognition. Pulmonary sporotrichosis presents with distinct clinical and radiological patterns in both immunocompetent and immunocompromised hosts and can often result in significant morbidity and mortality despite treatment. Current understanding regarding S. schenckii biology, epidemiology, immunopathology, clinical diagnostics, and treatment options has been evolving in the recent years with increased availability of molecular sequencing techniques. However, this changing knowledge has not yet been fully translated into a better understanding of the clinical aspects of pulmonary sporotrichosis, as such current management guidelines remain unsupported by high-level clinical evidence. This article examines recent advances in the knowledge of sporotrichosis and its application to the difficult challenges of managing pulmonary sporotrichosis. © 2015 by thie Medical publishers,inc.

UR - https://www.ncbi.nlm.nih.gov/pubmed/26398541

U2 - 10.1055/s-0035-1562901

DO - 10.1055/s-0035-1562901

M3 - Review Article

VL - 36

SP - 756

EP - 766

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 5

ER -